Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.41 |
| ▸ | NQO2 | P16083 | 1/20 | 0.40 |
| ▸ | MAPT | P10636 | 5/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.36 |
| ▸ | GABRP | O00591 | 2/20 | 0.35 |
| ▸ | GABRD | O14764 | 2/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 2/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 2/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 2/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 2/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 2/20 | 0.35 |
| ▸ | GABRE | P78334 | 2/20 | 0.35 |
| ▸ | GABRA6 | Q16445 | 2/20 | 0.35 |
| ▸ | GABRG1 | Q8N1C3 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25682427 | 0.86 | GPR3 (0.39) | GPR3NQO2MAPTHTTKIF11 | |
| SCHEMBL25993506 | 0.85 | GPR3 (0.40) | GPR3NQO2MAPTHTTKIF11 | |
| SCHEMBL15447745 | 0.83 | KDM4E (0.42) | MAPTKIF11KDM4EALDH1A1HPGD | |
| SCHEMBL25682451 | 0.82 | GPR3 (0.36) | GPR3NQO2MAPTHTTKIF11 | |
| SCHEMBL25682667 | 0.82 | ALKBH5 (0.47) | GPR3MAPTHTTKIF11KDM4E | |
| SCHEMBL13183789 | 0.81 | GPR3 (0.47) | GPR3NQO2MAPTHTTKIF11 | |
| SCHEMBL25523152 | 0.80 | GPR3 (0.54) | GPR3NQO2MAPTHTTKIF11 | |
| SCHEMBL25682449 | 0.80 | KIF11 (0.43) | GPR3NQO2MAPTHTTKIF11 | |
| SCHEMBL25993483 | 0.78 | MAPT (0.34) | GPR3MAPTHTTKIF11KDM4E | |
| SCHEMBL25993604 | 0.78 | GPR3 (0.41) | GPR3NQO2MAPTHTTKIF11 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | KYULUX, INC. (JP) | 2023-08-24 | — | — | US | disclosed |
| EP-4190791-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | Kyulux, Inc. (JP) | 2023-06-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230265106-A1 | COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT | CRY1, CCNE2, CRY2 | GPR3 1535/4885NQO2 1364/4885MAPT 1225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.